Lupid Ltd. Recalls Antibacterial Drugs After Failing to Meet Standards

According to the Wall Street Journal, Indian drug manufacturer Lupin Ltd. is recalling thousands of bottles of antibacterial drugs in the U.S. after finding that they failed to meet standards for impurities.

The paper reported that the company, based in Baltimore in the U.S., has recalled close to 10,000 bottles of the drug made by its Indian parent, Lupin Ltd. The recall was reportedly initiated on January 27.

“This is a voluntary recall initiated on our own and of no business consequence,” a Lupin representative said, according to the Journal.

Lupin is the fifth-largest generic drug manufacturer in the U.S. in terms of prescriptions, getting 40 percent of its net sales from the country, according to the Journal.

The recall includes Lupin’s branded drug Suprax, the brand name for cefixime, which is an antibiotic used to treat bacterial infections of the ear and upper respiratory tract.

What Should I Do If I Have Been Injured By a Recalled Drug?

Recalled drugs, especially ones used to treat infections, can pose a serious threat to the public. Impurities as a condition for a recall could include foreign substances being found in the medication.

Poor hygiene in pharmacies can have a major impact on the makeup of a drug. For example, the New England Compounding Company (NECC) recall of 2013 led to the death of more than 60 people after steroid treatments were found to be contaminated.

Our defective drug attorneys at the law firm of Zoll, Kranz & Borgess, LLC represent victims and the families of victims injured or killed because of recalled drugs. Contact us at (888) 841-9623
for a free consultation.

Zoll, Kranz & Borgess, LLC – Defective Medical Drug and Device Lawyers

Source: http://online.wsj.com/news/articles/SB10001424052702303887804579501211965450366